HOME > MARKETS > MARKET COMMENTARY
  MARKET COMMENTARY
EQUITY
Krebs Biochemicals & Industries informs about certificate
Apr-07-2026
In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, Krebs Biochemicals & Industries has informed that it enclosed a copy of the Certificates received from KFIN Technologies, the Registrar and Share Transfer Agent of the Company for the quarter ended March 31, 2026.

The above information is a part of company’s filings submitted to BSE.
  RELATED NEWS >>